Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exagen (XGN) Interest Expenses (2018 - 2025)

Historic Interest Expenses for Exagen (XGN) over the last 8 years, with Q3 2025 value amounting to $1.3 million.

  • Exagen's Interest Expenses rose 13469.75% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year increase of 5873.94%. This contributed to the annual value of $2.2 million for FY2024, which is 432.55% down from last year.
  • As of Q3 2025, Exagen's Interest Expenses stood at $1.3 million, which was up 13469.75% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, Exagen's Interest Expenses ranged from a high of $1.3 million in Q3 2025 and a low of $545000.0 during Q1 2025
  • Over the past 5 years, Exagen's median Interest Expenses value was $606000.0 (recorded in 2022), while the average stood at $664736.8.
  • Per our database at Business Quant, Exagen's Interest Expenses crashed by 1394.98% in 2024 and then soared by 13469.75% in 2025.
  • Quarter analysis of 5 years shows Exagen's Interest Expenses stood at $639000.0 in 2021, then fell by 2.03% to $626000.0 in 2022, then dropped by 9.58% to $566000.0 in 2023, then decreased by 0.53% to $563000.0 in 2024, then soared by 134.28% to $1.3 million in 2025.
  • Its last three reported values are $1.3 million in Q3 2025, $1.1 million for Q2 2025, and $545000.0 during Q1 2025.